Funding · Company
858 Therapeutics, Inc.
San Diego, CABiotech & Pharma
858 Therapeutics, Inc. of San Diego, CA has disclosed $25M across 1 Form D offering filed with the SEC on Jul 11, 2024.
$25M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$25M
Form D · Jul 11, 2024 ↗
Q3 2024
· target $50M
Filing details
HeadquartersSan Diego, CAIndustryBiotech & Pharma (Pharmaceuticals)SEC CIK0001806356Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →